Lallemand Pharma

Lallemand Pharma, a Switzerland based company, possesses the intellectual property rights of an immunostimulant drug indicated in the prevention of respiratory infections known as PMBL sublingual tablet brought rights of IMC off-the-shelf portal www_dot_allabouth1n1flu_dot_com.

IMC conceptualized, designed and developed a H1N1 awareness portal focusing on physician education for better patient care.